These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [On the problem of biologically effective marginal concentrations in carbon dioxide gas baths]. Tolle U; Dirnagl K; Drexel H Arch Phys Ther (Leipz); 1966; 18(3):215-7. PubMed ID: 6003326 [No Abstract] [Full Text] [Related]
44. [Carbonate mineral baths in the combined treatment at a piedmont health resort of patients operated on for rheumatic heart defects]. Amiiants VIu; Veres AA; Bidzhieva ZN; Gromova GV Vopr Kurortol Fizioter Lech Fiz Kult; 2000; (4):15-8. PubMed ID: 11008566 [TBL] [Abstract][Full Text] [Related]
45. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
46. [Treatment of systemic scleroderma]. Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467 [No Abstract] [Full Text] [Related]
47. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Rose RF; Turner D; Goodfield MJ; Goulden V Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995 [TBL] [Abstract][Full Text] [Related]
48. Update on management of scleroderma. Sule SD; Wigley FM Bull Rheum Dis; 2000; 49(10):1-4. PubMed ID: 11286150 [No Abstract] [Full Text] [Related]
50. [Treatment of scleroderma by parathyroidectomy]. STRICKER P Strasb Med; 1951 Oct; 2(10):608-16. PubMed ID: 14901210 [No Abstract] [Full Text] [Related]
51. Treatment of localized forms of scleroderma. ZARAFONETIS CJ Am J Med Sci; 1962 Feb; 243():147-58. PubMed ID: 14009873 [No Abstract] [Full Text] [Related]
52. [Treatment of scleroderma by chelation]. CORRALES H Rev Med Hondur; 1960; 28():84-7. PubMed ID: 13695652 [No Abstract] [Full Text] [Related]
53. The treatment of scleroderma. WINKELMANN RK; BRUNSTING LA Minn Med; 1959 Jan; 42(1):13-5 passim. PubMed ID: 13622457 [No Abstract] [Full Text] [Related]
54. [Result of treatment of scleroderma with lidase]. KHMEL'NITSKII RKh Vestn Dermatol Venerol; 1958; 32(4):66-8. PubMed ID: 13593098 [No Abstract] [Full Text] [Related]
55. [Treatment of scleroderma with alpha-tocopherol]. BOZKOWA K Pol Tyg Lek (Wars); 1957 Apr; 12(16):606-8. PubMed ID: 13452974 [No Abstract] [Full Text] [Related]
56. [Artane in the treatment of scleroderma]. CORDERO AA; CORTI RN Prensa Med Argent; 1953 Oct; 40(43):2911-4. PubMed ID: 13120690 [No Abstract] [Full Text] [Related]
57. [Treatment problems in systemic scleroderma using hyperbaric oxygenation]. Lukich VL; Grebenev AL; Matrenitskaia NA; Grabskiĭ MA Klin Med (Mosk); 1984 Mar; 62(3):26-31. PubMed ID: 6716924 [No Abstract] [Full Text] [Related]
58. [Therapeutic effects of carbon dioxide mineral baths in patients with chronic obstructive lung disease]. Golich LG; Ponomarenko GN Vopr Kurortol Fizioter Lech Fiz Kult; 2003; (1):32-6. PubMed ID: 12698705 [No Abstract] [Full Text] [Related]
59. Carbogen gas for treatment of sudden deafness. Hender KM; Anderson JN; Vallance NA Med J Aust; 2002 Apr; 176(8):387-8. PubMed ID: 12041636 [No Abstract] [Full Text] [Related]
60. [Systemic sclerosis--clinical course and treatment possibilities]. Szymańska E; Maj M; Rudnicka L Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]